姚庆华, 郭勇. 薏苡仁甘油三酯(康莱特)治疗晚期恶性肿瘤患者机制研究进展[J]. 中国肿瘤临床, 2012, 39(16): 1151-1154. DOI: 10.3969/j.issn.1000-8179.2012.16.004
引用本文: 姚庆华, 郭勇. 薏苡仁甘油三酯(康莱特)治疗晚期恶性肿瘤患者机制研究进展[J]. 中国肿瘤临床, 2012, 39(16): 1151-1154. DOI: 10.3969/j.issn.1000-8179.2012.16.004
Qinghua YAO, Yong GUO. Research Progress in Coix Seed Triglycerides(KLT) Mechanism in Treatment of Patients with Advanced Malignant Tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(16): 1151-1154. DOI: 10.3969/j.issn.1000-8179.2012.16.004
Citation: Qinghua YAO, Yong GUO. Research Progress in Coix Seed Triglycerides(KLT) Mechanism in Treatment of Patients with Advanced Malignant Tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(16): 1151-1154. DOI: 10.3969/j.issn.1000-8179.2012.16.004

薏苡仁甘油三酯(康莱特)治疗晚期恶性肿瘤患者机制研究进展

Research Progress in Coix Seed Triglycerides(KLT) Mechanism in Treatment of Patients with Advanced Malignant Tumors

  • 摘要: 薏苡仁甘油三酯是薏苡仁中主要的抗肿瘤活性成份, 其制剂康莱特注射液为双相广谱抗肿瘤、可供静脉直接输注的新型脂肪乳剂。研究表明, 康莱特注射液在肺、肝、脑、乳腺等多种癌症治疗中均有较好疗效, 特别在原发性肝癌和晚期非小细胞癌的治疗中有显著疗效, 且副作用较少。在控制癌变的同时还能增加患者的机体免疫力, 延长疾病的进展时间, 很大程度上提高了临床疗效。本文主要阐述近些年薏苡仁甘油三酯在晚期恶性肿瘤中的疗效和作用机制的研究进展。

     

    Abstract: The coix ester and triglyceride are the main active ingredients with antitumor properties in semen coicis. Its therapeutic agent, the Kanglaite injection, is a new broad-spectrum type of antitumor diphase emulsion, which can be intravenously administered. In recent years, various studies have demonstrated that a good curative effect could be observed among the several chemotherapeutic regimens using the Kanglaite injection, particularly the non-small cell lung cancer and primary liver cancer, with only mild toxicity. Kanglaite injection can prevent the development of lung cancer, as well as increase the immunity of patients and enhance the clinical efficacy of other treatments. This thesis mainly studies the recent antitumor mechanisms and applications of KLT in the treatment of pancreatic malignant tumors.

     

/

返回文章
返回